This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2y5l
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | + | ==ORALLY ACTIVE AMINOPYRIDINES AS INHIBITORS OF TETRAMERIC FRUCTOSE 1,6-BISPHOSPHATASE== | |
| - | + | <StructureSection load='2y5l' size='340' side='right' caption='[[2y5l]], [[Resolution|resolution]] 2.20Å' scene=''> | |
| - | { | + | == Structural highlights == |
| + | <table><tr><td colspan='2'>[[2y5l]] is a 8 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2Y5L OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2Y5L FirstGlance]. <br> | ||
| + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=RO8:N-{[(2Z)-5-BROMO-1,3-THIAZOL-2(3H)-YLIDENE]CARBAMOYL}-3-CHLOROBENZENESULFONAMIDE'>RO8</scene></td></tr> | ||
| + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2jjk|2jjk]], [[2wbd|2wbd]], [[2fhy|2fhy]], [[2fix|2fix]], [[1fta|1fta]], [[2vt5|2vt5]], [[2fie|2fie]], [[2wbb|2wbb]], [[2y5k|2y5k]]</td></tr> | ||
| + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Fructose-bisphosphatase Fructose-bisphosphatase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.3.11 3.1.3.11] </span></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2y5l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2y5l OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2y5l RCSB], [http://www.ebi.ac.uk/pdbsum/2y5l PDBsum]</span></td></tr> | ||
| + | </table> | ||
| + | == Disease == | ||
| + | [[http://www.uniprot.org/uniprot/F16P1_HUMAN F16P1_HUMAN]] Defects in FBP1 are the cause of fructose-1,6-bisphosphatase deficiency (FBPD) [MIM:[http://omim.org/entry/229700 229700]]. FBPD is inherited as an autosomal recessive disorder mainly in the liver and causes life-threatening episodes of hypoglycemia and metabolic acidosis (lactacidemia) in newborn infants or young children.<ref>PMID:9382095</ref> <ref>PMID:12126934</ref> | ||
| + | == Function == | ||
| - | == | + | <div style="background-color:#fffaf0;"> |
| - | + | == Publication Abstract from PubMed == | |
| + | A novel sulfonylureido pyridine series exemplified by compound 19 yielded potent inhibitors of FBPase showing significant glucose reduction and modest glycogen lowering in the acute db/db mouse model for Type-2 diabetes. Our inhibitors occupy the allosteric binding site and also extend into the dyad interface region of tetrameric FBPase. | ||
| - | + | Orally active aminopyridines as inhibitors of tetrameric fructose-1,6-bisphosphatase.,Hebeisen P, Haap W, Kuhn B, Mohr P, Wessel HP, Zutter U, Kirchner S, Ruf A, Benz J, Joseph C, Alvarez-Sanchez R, Gubler M, Schott B, Benardeau A, Tozzo E, Kitas E Bioorg Med Chem Lett. 2011 Jun 1;21(11):3237-42. Epub 2011 Apr 20. PMID:21550236<ref>PMID:21550236</ref> | |
| - | + | ||
| + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| + | </div> | ||
==See Also== | ==See Also== | ||
*[[Fructose-1%2C6-bisphosphatase|Fructose-1%2C6-bisphosphatase]] | *[[Fructose-1%2C6-bisphosphatase|Fructose-1%2C6-bisphosphatase]] | ||
| - | + | == References == | |
| - | == | + | <references/> |
| - | + | __TOC__ | |
| + | </StructureSection> | ||
[[Category: Fructose-bisphosphatase]] | [[Category: Fructose-bisphosphatase]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
| - | [[Category: Alvarez-Sanchez, R | + | [[Category: Alvarez-Sanchez, R]] |
| - | [[Category: Benardeau, A | + | [[Category: Benardeau, A]] |
| - | [[Category: Benz, J | + | [[Category: Benz, J]] |
| - | [[Category: Gubler, M | + | [[Category: Gubler, M]] |
| - | [[Category: Haap, W | + | [[Category: Haap, W]] |
| - | [[Category: Hebeisen, P | + | [[Category: Hebeisen, P]] |
| - | [[Category: Joseph, C | + | [[Category: Joseph, C]] |
| - | [[Category: Kirchner, S | + | [[Category: Kirchner, S]] |
| - | [[Category: Kitas, E | + | [[Category: Kitas, E]] |
| - | [[Category: Kuhn, B | + | [[Category: Kuhn, B]] |
| - | [[Category: Mohr, P | + | [[Category: Mohr, P]] |
| - | [[Category: Ruf, A | + | [[Category: Ruf, A]] |
| - | [[Category: Schott, B | + | [[Category: Schott, B]] |
| - | [[Category: Tozzo, E | + | [[Category: Tozzo, E]] |
| - | [[Category: Wessel, H P | + | [[Category: Wessel, H P]] |
| - | [[Category: Zutter, U | + | [[Category: Zutter, U]] |
[[Category: Hydrolase]] | [[Category: Hydrolase]] | ||
Revision as of 14:12, 18 December 2014
ORALLY ACTIVE AMINOPYRIDINES AS INHIBITORS OF TETRAMERIC FRUCTOSE 1,6-BISPHOSPHATASE
| |||||||||||
Categories: Fructose-bisphosphatase | Homo sapiens | Alvarez-Sanchez, R | Benardeau, A | Benz, J | Gubler, M | Haap, W | Hebeisen, P | Joseph, C | Kirchner, S | Kitas, E | Kuhn, B | Mohr, P | Ruf, A | Schott, B | Tozzo, E | Wessel, H P | Zutter, U | Hydrolase
